Core Viewpoint - Ipsen announces the appointment of Pierrick Lefranc as Executive Vice President (EVP) and member of the Executive Leadership Team (ELT), effective April 1, 2026, succeeding Aidan Murphy who will retire after 30 years with the company [1][12]. Group 1: Leadership Transition - Pierrick Lefranc brings over 30 years of experience in the pharmaceutical industry, having led manufacturing operations and large-scale industrial projects, focusing on productivity, quality, and regulatory compliance [2]. - Since July 2019, Lefranc has served as Senior Vice President at Ipsen, overseeing global manufacturing activities and engineering [2]. - David Loew, CEO of Ipsen, expressed confidence in Lefranc's leadership and strategic transformation expertise, while also acknowledging Aidan Murphy's significant contributions to the company [3]. Group 2: Company Overview - Ipsen is a global biopharmaceutical company focused on transformative medicines in oncology, rare diseases, and neuroscience, with nearly 100 years of development experience [4]. - The company operates in over 40 countries and partners globally to deliver medicines to patients in more than 100 countries [4].
Pierrick Lefranc appointed as Executive Vice President Technical Operations, member of Executive Leadership Team
Globenewswire·2026-01-27 06:00